sur MeVis Medical Solutions AG (ETR:M3V)
MeVis Medical Solutions AG Revises Fiscal Forecast
Bremen, September 28, 2026 – MeVis Medical Solutions AG has announced a downward revision of its financial forecast for the 2025/2026 fiscal year. The leading software company specializing in image-based medicine cited subdued demand in the mammography sector for its customer Hologic and a slow rollout of lung cancer screening in Germany as primary factors impacting revenue.
Preliminary figures suggest expected revenue will decrease to between €15.0 million and €15.5 million, down from the previously forecasted €16.5 million to €17.0 million. Consequently, the company anticipates negative earnings before interest and taxes (EBIT), projected to be between € -1.0 million and € -1.5 million, assuming a stable exchange rate of 1.16 USD/EUR.
R. E.
Copyright © 2026 FinanzWire, tous droits de reproduction et de représentation réservés.
Clause de non responsabilité : bien que puisées aux meilleures sources, les informations et analyses diffusées par FinanzWire sont fournies à titre indicatif et ne constituent en aucune manière une incitation à prendre position sur les marchés financiers.
Cliquez ici pour consulter le communiqué de presse ayant servi de base à la rédaction de cette brève
Voir toutes les actualités de MeVis Medical Solutions AG